Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich's Ataxia
Stock Information for Solid Biosciences Inc.
Loading
Please wait while we load your information from QuoteMedia.